Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Xenetic Biosciences, Inc. (XBIO) had Pre-Tax Profit Margin of -152.23% for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$0.59M |
|
$-0.90M |
|
-- |
|
$0.59M |
|
$1.54M |
|
$-0.94M |
|
$0.04M |
|
$-0.90M |
|
$-0.90M |
|
$-0.90M |
|
$-0.90M |
|
$-0.90M |
|
$-0.90M |
|
$-0.94M |
|
$-0.94M |
|
1.54M |
|
1.54M |
|
$-0.59 |
|
$-0.59 |
|
Balance Sheet Financials | |
$5.48M |
|
-- |
|
$0.31M |
|
$5.79M |
|
$0.67M |
|
-- |
|
-- |
|
$0.67M |
|
$5.12M |
|
$5.12M |
|
$5.12M |
|
1.54M |
|
Cash Flow Statement Financials | |
$-1.00M |
|
-- |
|
-- |
|
$6.17M |
|
$5.16M |
|
$-1.00M |
|
$0.02M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
8.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-158.85% |
|
-158.85% |
|
-- |
|
Pre-Tax Profit Margin |
-152.23% |
-152.23% |
|
$-1.00M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-17.63% |
|
-17.63% |
|
-15.60% |
|
-17.63% |
|
$3.32 |
|
$-0.65 |
|
$-0.65 |